Resolution of Leucocyte-Mediated Mucosal Diseases. A Novel in Vivo Paradigm for Drug Development

British Journal of Pharmacology - United States
doi 10.1111/j.1476-5381.2011.01772.x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Development of Application of Novel Oral and Mucosal Drug Delivery Systems

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2014English

A New in Vivo Screening Paradigm to Accelerate Antimalarial Drug Discovery

PLoS ONE
Multidisciplinary
2013English

Drug Development in Pemphigoid Diseases

Acta Dermato-Venereologica
DermatologyMedicine
2020English

A Novel Actin Binding Drug With in Vivo Efficacy

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Development of a Novel Plant Activator for Rice Diseases, Tiadinil

Journal of Pesticide Sciences
MutagenesisHealthInsect ScienceToxicology
2006English

Development of a Novel Plant Activator for Rice Diseases, Tiadinil

Journal of Pesticide Sciences
MutagenesisHealthInsect ScienceToxicology
2006English

Drug Development to Protozoan Diseases

Open Medicinal Chemistry Journal
Drug DiscoveryMolecular MedicinePharmacologyPharmaceutical Science
2011English

Mucosal-Associated Invariant T Cells in Autoimmunity, Immune-Mediated Diseases and Airways Disease

Immunology
AllergyImmunology
2016English

Toll-Like Receptor-Mediated Immune Responses in Intestinal Macrophages; Implications for Mucosal Immunity and Autoimmune Diseases

Clinical Immunology
AllergyImmunology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy